Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

October 30, 2018 Leave a comment 1,458 Views

AMPEL BioSolutions announced proof-of-principle for a multi-pronged approach to rank small molecules and biologics for safe, effective treatment of patients with Systemic Lupus Erythematosus (SLE) and...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Stelara

Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

Learn more about available bioinformatics tools and pipelines to analyze RNA sequencing data

New search engine for single cell atlases

Yale researchers identify tumor reactive immune cells with RNA sequencing to help fight against advanced melanoma

New algorithm identifies ‘escaping’ cells in single-cell CRISPR screens

RNA sequencing brings hope for endangered wild cats

Mim-tRNAseq – A method that accurately measures the abundance and modification status of different tRNAs

Uncovering the Anti-Myeloma Resistance Files